(Q31955959)

5 July 2017

title

Glucose scavenging of nitric oxide (English)

1 reference

5 July 2017

Brodsky SV

1

1 reference

5 July 2017

Morrishow AM

2

1 reference

5 July 2017

Dharia N

3

1 reference

5 July 2017

Gross SS

4

1 reference

5 July 2017

Goligorsky MS

5

1 reference

5 July 2017

publication date

1 March 2001

1 reference

American Journal of Physiology - Renal Physiology

5 July 2017

published in

1 reference

5 July 2017

volume

280

1 reference

5 July 2017

issue

3

1 reference

5 July 2017

page(s)

F480-6

1 reference

High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation.

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Nitric oxide: an endogenous modulator of leukocyte adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Characterization of bovine endothelial nitric oxide synthase expressed in E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Antioxidant pyrrolidine dithiocarbamate prevents defective bradykinin-stimulated calcium accumulation and nitric oxide activity following exposure of endothelial cells to elevated glucose concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2001.280.3.F480

10.1152/AJPRENAL.2001.280.3.F480

21 January 2018

Identifiers

DOI

0 references

1 reference